Tag Archives: clinical research

Response to Carolyn from MyHeartSisters.org

NOTE: We encourage you to read the substantial comment left by Carolyn Thomas, who writes over at http://www.myheartsisters.org. The comment was written on Dr. DeFelice’s previous post on the cardiovascular promise of vitamin E. The note below is in response to her remarks. Dear Mrs. Thomas, The nutrition world is confusing and for a number of reasons, […]

Read more

Eggcentric or Not? For the Love of Grandchildren!

I gave birth to my only son when I was 39 years old. I had been listening to the proverbial biological ticking clock but not paying much attention as I was enjoying my career. When my son was about 8 years old he asked me, “Mom, shouldn’t I be older or you be younger?” Most […]

Read more

Why aren’t Hypertensive patients mad?

Renal Denervation: Exciting Promise for the Treatment of Drug- Resistant Hypertension. Why Aren’t Hypertensive Patients Mad? Another Reason for the Doctornaut Act Currently, in the United States alone there are approximately 76 million  hypertensive patients, about 9 million of whom are resistant to drug therapy making them highly vulnerable to heart attacks, strokes and heart […]

Read more

DeFelice of Westfield Keynote Speaker at Geneva Nutraceutical Conference

The Westfield Leader published an article about my keynote speech in Geneva. Take a look below or go over to the Leader and read it online.

Read more

VIDEO: Nutraceutical industry needs new trial design culture

Dr. DeFelice sat down with the respected NutraIngredients.com reporter Shane Starling to talk about the state of the nutraceutical industry and the need for a new design culture. The multi-billion euro global nutraceutical industry will never achieve its potential until it better adapts pharma protocols – and this can be done with food nutrients, says […]

Read more

The Potential Nutraceutical Market

Stephen L. DeFelice, M.D., just finished speaking at the 2012 Vitafoods Conference in Geneva, Switzerland. In his speech he spoke about the potential for a nutraceutical market, and the state of the current traditional dietary supplement and food markets. Dr. DeFelice also wrote a paper on the same subject, take a look at it below. The picture […]

Read more

Vitafoods Europe Conference This Week!

This week, Dr. DeFelice is joining thousands of highly respected doctors, business leaders, and nutritionists at the annual Vitafoods Europe conference. If you haven’t done it already, check out the Vitafoods website for more information about this annual event. After Dr. DeFelice’s presentation on the future of nutraceuticals, we’ll be posting a paper he wrote for […]

Read more

Time to re-introduce and debate The Doctornaut Act in Congress

In previous posts I wrote about the unrecognized disastrous health policies that prevent the discovery of medical advances, including cures. Just ask yourself when the last cure was. As a result, millions of patients suffer when they shouldn’t, and die before they should. One critical reason for the absence of cures is due to the extreme […]

Read more

Two Wall Street Journal Articles Make a Compelling Argument for the Doctornaut Act

In the April 16, 2012 Wall Street Journal, one article dealt with an ALS (Lou Gehrig’s disease) patient having problems having access to a new potential therapy which is being clinically studied in a specific ALS population therapy. The patient is too far advanced to qualify as a volunteer for the study. Even if the […]

Read more

Clinical Research in the News: April 17, 2012

Over the upcoming weeks and months, one of our goals is to help our readers understand the benefits of clinical research and why it’s essential to finding cures to diseases, and the current legal and regulatory climate that makes it difficult for scientists and doctors to perform this research. Clinical research is always complex and […]

Read more